Investor Center
AngioDynamics is a leading provider of innovative medical devices used by interventional radiologists, interventional cardiologists, surgeons, and other physicians for the minimally-invasive diagnosis and treatment of cancer and peripheral vascular disease.
Founded in Queensbury in 1988, AngioDynamics and has grown into a NASDAQ-listed public company. Having distinguished itself as a dynamic brand in a technologically competitive, high-growth industry, AngioDynamics sells its products in the U.S. through a direct sales force, and in international markets through a combination of direct sales and distributors.
More »
Recent Presentations
May 21, 2013
UBS Presentation
Jan 23, 2013
Analyst Day Presentation
Recent Releases
May 14, 2013
AngioDynamics to Present at UBS Global Healthcare Conference
Apr 8, 2013
AngioDynamics Reports Fiscal 2013 Third Quarter Financial Results
